Interim PET/CT-adapted Use of PD-1 Inhibitor Combined With De-escalated Chemotherapy-AVD in Classic Hodgkin Lymphoma
Clinical trial NCT07720011 · COMPLETED
Trial details
- NCT number
- NCT07720011
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2026-02-28
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.